The potential health risk of a group of chemicals, popularly known as "endo
crine disrupters," has generated considerable scientific debate and media a
ttention. The endocrine disrupter hypothesis asserts that exogenous substan
ces with estrogenic or other hormonally active properties may adversely aff
ect human health. Proponents of this hypothesis have associated endocrine m
odulators with negative outcomes such as cancer in hormonally sensitive tis
sues and declining sperm counts in men. However, the available laboratory,
wildlife, and epidemiological data do not provide consistent or convincing
evidence that industrial chemicals suspected of modulating estrogenic pathw
ays are related to adverse health effects in humans. Both public and privat
e initiatives are investigating chemicals labeled as endocrine disrupters f
or their relative hormonal activity. Screening assays aimed at assessing th
e endocrine activity or potential of a variety of substances should not be
confused with assessment of risk to humans, however. The latter entails not
only hazard identification (the type of information that screening assays
are designed to provide), but also critical factors such as exposure analys
is, potency assessment, and dose-response for individual chemicals, (C) 200
0 Academic Press.